Paul H. Gumerlock

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Reginald V. Lord, Jan Brabender, David R. Gandara et al. · PubMed · 2002 · 671 citations

Medicine, Molecular Biology, Oncology +14

Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

Fred R. Hirsch, Marileila Varella‐Garcia, Jason McCoy et al. · Journal of Clinical Oncology · 2005 · 584 citations · Full text

Medicine, Oncology, Pharmacology +16

Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504

David R. Gandara, Kari Chansky, Kathy S. Albain et al. · Journal of Clinical Oncology · 2003 · 374 citations

Medicine, Oncology, Pharmacotherapy +17

Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells

Jiann-an Tan, Yousuf Sharief, Katherine G. Hamil et al. · Molecular Endocrinology · 1997 · 359 citations · Full text

Medicine, Molecular Biology, Oncology +17

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Fred R. Hirsch, Marileila Varella‐Garcia, Federico Cappuzzo et al. · Annals of Oncology · 2007 · 270 citations · Full text

Medicine, Molecular Genetics, Oncology +16